Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL)
Clinical trial NCT01724879 · COMPLETED
Trial details
- NCT number
- NCT01724879
- Sponsor
- Goethe University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2015-09-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.